|
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices, focusing on therapeutic areas such as aesthetics, diagnostics, physiotherapy, life sciences among others. JDHL's facility is FDA / MDSAP compliant, ensuring the highest quality and safety standards, and meeting the regulatory requirements in the US, Australia, Canada, Brazil and Japan. JDHL also has multiple FDA 510(k) approvals in place for its various products.
This acquisition will enhance Syrma SGS's capabilities and offerings in the electro-medical devices segment and create business synergies across multiple areas. Syrma SGS expects the acquisition to be accretive to its earnings and cash flow.
On 1 August 2023, the company has entered into definitive agreements to acquire 51% stake in Johari Digital Healthcare an end to end design-led manufacturer of electro-medical devices, for a consideration of Rs 229.5 crore.
Syrma SGS Technology is a technology-focussed engineering and design company engaged in turnkey electronics manufacturing services ("EMS"), specialising in precision manufacturing for diverse end-use industries, including industrial appliances, automotive, healthcare, consumer products and IT industries.
The company's consolidated net profit jumped 93.1% to Rs 28.52 crore in Q1 FY24 as compared with Rs 15.58 crore in Q1 FY23. Net sales jumped 54.4% year on year to Rs 601.31 crore in Q1 FY24.
|